These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24588662)

  • 21. Deciding on the appropriate pharmacotherapy for the treatment of endometriosis.
    Carneiro MM
    Expert Opin Pharmacother; 2023 Jan; 24(1):1-5. PubMed ID: 35973977
    [No Abstract]   [Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.
    Judd HL
    Am J Obstet Gynecol; 1992 Feb; 166(2):752-6. PubMed ID: 1531578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Limited effect of gonadotrophin-releasing hormone analogues for patients with endometriosis].
    Seyer-Hansen M; Kruse C
    Ugeskr Laeger; 2012 Jun; 174(24):1671-3. PubMed ID: 22681992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects].
    Racine AC; Legrand E; Lefebvre-Lacoeuille C; Hoppe E; Catala L; Sentilhes L; Descamps P
    Gynecol Obstet Fertil; 2010 May; 38(5):318-23. PubMed ID: 20430665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Bedaiwy MA; Allaire C; Alfaraj S
    Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical therapy with leuprorelin acetate for endometriosis in the United States.
    Olive DL
    Drugs Today (Barc); 2005 Jul; 41 Suppl A():5-10. PubMed ID: 16200219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of endometriosis.
    Olive DL; Pritts EA
    N Engl J Med; 2001 Jul; 345(4):266-75. PubMed ID: 11474666
    [No Abstract]   [Full Text] [Related]  

  • 29. A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis.
    Fedele L; Bianchi S; Montefusco S; Frontino G; Carmignani L
    Fertil Steril; 2008 Jul; 90(1):183-4. PubMed ID: 18177868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group.
    Surrey ES
    Fertil Steril; 1999 Mar; 71(3):420-4. PubMed ID: 10065775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of pelvic pain associated with endometriosis.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S260-9. PubMed ID: 19007642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review.
    Donnez J; Cacciottola L; Squifflet JL; Dolmans MM
    Drug Des Devel Ther; 2023; 17():369-380. PubMed ID: 36789095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guidelines for the management of painful endometriosis].
    Roman H; Puscasiu L
    Chirurgia (Bucur); 2008; 103(3):265-74. PubMed ID: 18717274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometriosis: clinical assessment and medical management.
    Stockwell J
    Adv Nurse Pract; 2006 Jan; 14(1):43-5. PubMed ID: 16425515
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
    Gargiulo AR; Hornstein MD
    Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of medical treatment of endometriosis on bone mass.
    Dawood MY
    Am J Obstet Gynecol; 1993 Feb; 168(2):674-84. PubMed ID: 8438949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dienogest: a review of its use in the treatment of endometriosis.
    McCormack PL
    Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometriosis: current and future medical therapies.
    Vercellini P; Somigliana E; Viganò P; Abbiati A; Daguati R; Crosignani PG
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):275-306. PubMed ID: 18036995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
    Grow DR; Williams RF; Hsiu JG; Hodgen GD
    J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.